Merit Medical Systems, Inc. (MMSI) Cash Flow Statement

The persistent gap between net income and operating cash flow suggests that the company's earnings quality is heavily influenced by non-cash expenses rather than pure operational efficiency. Investors should monitor whether this divergence indicates a structural reliance on capital-intensive manufacturing assets that require constant reinvestment to maintain competitive positioning.

This inconsistency in free cash flow generation may indicate that the company's cash-generating ability is sensitive to the timing of large-scale operational projects or acquisition-related integration costs. The lack of a smooth FCF trajectory warrants further investigation into whether management can stabilize cash conversion as the business scales.

The frequent swings in working capital appear to reflect the complexities of managing a vast SKU catalog and the logistical demands of custom procedural kits. Investors should consider whether these fluctuations are inherent to the company's supply chain model or if they represent inefficiencies in inventory turnover that could be optimized.

The company's reliance on tuck-in acquisitions to drive growth appears to be the primary use of its generated cash, which may limit the flexibility to return capital to shareholders. This strategy necessitates a high degree of confidence in management's ability to integrate these assets and achieve accretive returns on invested capital over the long term.